DR. REDDY S LABORATORIES

NSE₹1,205.20·DRREDDY·INE089A01031

Previous session · source 2026-09-19Snapshot

Price chart

fast lightweight view

Market depth

live order book

Buy orders68.99%Sell orders31.01%

Resting bid and ask levels
Bid Price	Qty	Ask Price	Qty
1,186.10NSE	197	1,186.20NSE	330
1,186.00BSE	10	1,186.30NSE	388
1,186.00NSE	1,734	1,186.40NSE	116
1,185.95BSE	15	1,186.70NSE	79
1,185.90NSE	107	1,186.80NSE	48
1,185.85BSE	276	1,187.05BSE	29
1,185.80BSE	147	1,187.10BSE	8
1,185.75BSE	46	1,187.30BSE	21
1,185.70NSE	142	1,187.55BSE	21
1,185.60NSE	500	1,187.65BSE	387
Bid Total	3,174	Ask Total	1,427

1,182.60
Open: 1,207.50
High: 1,182.10
Low: 1,205.20
Close

Performance

Today’s lowToday’s high

₹1,182.10₹1,207.50

52-week low52-week high

₹1,130.00₹1,207.50

Open₹1,182.60

Prev close₹1,205.20

Volume23.49 L

Latest dividend₹8 · 10 Jul 26

Investor snapshot

fast read from available feeds

Price positionRange unavailableQuote unavailable

Profitability13%Latest ROCE

Growth+3.23%Revenue YoY, latest annual

Ownership26.6% promoterLatest shareholding

DerivativesF&O availableOption chain linked

Use this as a navigation aid. It summarizes feed observations, not a buy or sell view.

Financials

₹ crore

FY22

Revenue₹21,545 Cr

Net profit₹2,182 Cr

Op. cash flow—

FY23

Revenue₹24,670 Cr

Net profit₹4,507 Cr

Op. cash flow—

FY24

Revenue₹28,011 Cr

Net profit₹5,578 Cr

Op. cash flow—

FY25

Revenue₹32,644 Cr

Net profit₹5,725 Cr

Op. cash flow—

FY26

Revenue₹33,700 Cr

Net profit₹4,158 Cr

Op. cash flow—

Revenue and profit growth

latest Mar 2026

Revenue growth

1Y+3.23%

3Y CAGR+10.96%

Net profit growth

1Y−27.37%

3Y CAGR−2.65%

Historical returns

computed from available OHLC

1DNot available

1W+1.67%

1M+2.65%

3M+2.65%

6M+2.65%

1Y+2.65%

Company profile

Large cap company in Pharmaceuticals, part of the Healthcare sector.

SectorHealthcare

IndustryPharmaceuticals

Listed{'exchange': 'NSE', 'symbol': 'DRREDDY', 'status': 'Listed'}

Founded1984

HeadquartersHyderabad, India

ISININE089A01031

Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company engaged in the manufacture and marketing of pharmaceutical products. Its business includes global generics, pharmaceutical services and active ingredients (API), and other research-linked operations. The company serves markets in India and internationally.

Listed on NSE under the symbol DRREDDY.
Core segments include Global Generics and Pharmaceutical Services and Active Ingredients (PSAI).
Operates as an integrated pharmaceutical company with a presence in India and overseas markets.
Headquartered in Hyderabad, India.

Shareholding pattern

8 periods

Promoter26.63%

FII21.14%

DII30.72%

Retail & others21.27%